McGeorge Anne (CIK 1779934) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-11). Recent activity: Buy DNTH (1,250 shares), Buy DNTH (6,500 shares), Sell DNTH (1,450 shares), Sell DNTH (2,800 shares), Sell DNTH (1,800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Buy | 1,250 | $24,200 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Buy | 6,500 | $72,800 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 1,450 | $155,991 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 2,800 | $303,464 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 1,800 | $196,740 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 1,000 | $110,640 |
| 2026-08-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | Sell | 700 | $77,987 |
| 2026-07-29 | Oncology Institute, Inc. (TOI) | Director | Buy | 41,165 | $0 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 67,901 | $0 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 40,123 | $0 |
Source: SEC Form 4 filings · as of 2026-08-11